{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:56:38Z","timestamp":1791942998577,"version":"4.3.4"},"publisher-location":"Dordrecht","reference-count":121,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789400773585","type":"print"},{"value":"9789400773592","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T00:00:00Z","timestamp":1379376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T00:00:00Z","timestamp":1379376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-94-007-7359-2_18","type":"book-chapter","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T11:49:24Z","timestamp":1382356164000},"page":"361-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Carbonic Anhydrase Inhibitors and High Altitude Illnesses"],"prefix":"10.1007","author":[{"given":"Erik R.","family":"Swenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,17]]},"reference":[{"key":"18_CR1","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1007\/s00018-009-0145-9","volume":"66","author":"DM Bailey","year":"2009","unstructured":"Bailey DM, B\u00e4rtsch P, Knauth M, Baumgartner RW (2009) Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological. Cell Mol Life Sci 66:3583\u20133594","journal-title":"Cell Mol Life Sci"},{"key":"18_CR2","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1183\/09031936.98.12061242","volume":"12","author":"ER Swenson","year":"1998","unstructured":"Swenson ER (1998) Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression. Eur Respir J 12:1242\u20131247","journal-title":"Eur Respir J"},{"key":"18_CR3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1152\/japplphysiol.01407.2006","volume":"102","author":"ER Swenson","year":"2007","unstructured":"Swenson ER, Teppema L (2007) Prevention of acute mountain sickness: as yet an unfinished story. J Appl Physiol 102:1305\u20131307","journal-title":"J Appl Physiol"},{"key":"18_CR4","first-page":"R1283","volume":"297","author":"DM Bailey","year":"2009","unstructured":"Bailey DM, Taudorf S, Berg RM, Lundby C, McEneny J, Young IS, Evans KA, James PE, Shore A, Hulllin DA, McCord JM, Pedersen BK, M\u00f6ller K (2009) Increased cerebral output of free radicals during hypoxia: implications for acute mountain sickness? Am J Physiol 297:R1283\u2013R1292","journal-title":"Am J Physiol"},{"key":"18_CR5","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/jcbfm.2008.55","volume":"28","author":"K Kallenberg","year":"2008","unstructured":"Kallenberg K, Dehnert C, D\u00f6rfler A, Schellinger PD, Bailey DM, Knauth M, B\u00e4rtsch PD (2008) Microhemorrhages in nonfatal high-altitude cerebral edema. J Cereb Blood Flow Metab 28:1635\u20131642","journal-title":"J Cereb Blood Flow Metab"},{"key":"18_CR6","first-page":"303","volume":"20","author":"TH Maren","year":"1979","unstructured":"Maren TH (1979) An historical account of CO2 chemistry and the development of carbonic anhydrase inhibitors. Pharmacologist 20:303\u2013321","journal-title":"Pharmacologist"},{"key":"18_CR7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1378\/chest.69.1.112","volume":"69","author":"WL Coudon","year":"1976","unstructured":"Coudon WL, Block AJ (1976) Acute respiratory failure precipitated by a carbonic anhydrase inhibitor. Chest 69:112\u2013113","journal-title":"Chest"},{"key":"18_CR8","first-page":"1","volume":"67","author":"RS Kronenberg","year":"1967","unstructured":"Kronenberg RS, Cain SM (1967) Effects of acetazolamide on physiologic and subjective responses of men to 14,000 feet. SAM-TR-67\u201381. Sch Aviat Med Tech Rep 67:1\u201310","journal-title":"Sch Aviat Med Tech Rep"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJM196810172791601","volume":"279","author":"SA Forwand","year":"1968","unstructured":"Forwand SA, Landowne M, Follansbee JN, Hansen JE (1968) Effect of acetazolamide on acute mountain sickness. N Engl J Med 279:839\u2013845","journal-title":"N Engl J Med"},{"key":"18_CR10","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0002-9343(87)90937-5","volume":"83","author":"AJ Ellsworth","year":"1987","unstructured":"Ellsworth AJ, Larson EB, Strickland D (1987) A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis. Am J Med 83:1024\u20131030","journal-title":"Am J Med"},{"key":"18_CR11","first-page":"178","volume":"22","author":"B Kayser","year":"2012","unstructured":"Kayser B, Dumont L, Lysakowski C, Combescure C, Haller G, Tram\u00e8r MR (2012) Reappraisal of acetazolamide for the prevention of acute mountain sickness. Med Sci Sports Exerc 22:178\u20131841","journal-title":"Med Sci Sports Exerc"},{"key":"18_CR12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1249\/00005768-199002000-00009","volume":"22","author":"JM Stager","year":"1990","unstructured":"Stager JM, Tucker A, Cordain L, Engebretsen BJ, Brechue WF, Matulich CC (1990) Normoxic and acute hypoxic exercise tolerance in man following acetazolamide. Med Sci Sports Exerc 22:178\u2013184","journal-title":"Med Sci Sports Exerc"},{"key":"18_CR13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1152\/japplphysiol.00746.2001","volume":"94","author":"LA Garske","year":"2003","unstructured":"Garske LA, Brown MG, Morrison SC (2003) Acetazolamide reduces exercise capacity and increases leg fatigue under hypoxic conditions. J Appl Physiol 94:991\u2013996","journal-title":"J Appl Physiol"},{"key":"18_CR14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1152\/japplphysiol.00180.2007","volume":"103","author":"V Faoro","year":"2007","unstructured":"Faoro V, Huez S, Giltaire S (2007) Effects of acetazolamide on aerobic exercise capacity and pulmonary hemodynamics at high altitudes. J Appl Physiol 103:1161\u20131165","journal-title":"J Appl Physiol"},{"key":"18_CR15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00417991","volume":"57","author":"T McLellan","year":"1998","unstructured":"McLellan T, Jacobs I, Lewis W (1998) Acute altitude exposure and altered acid\u2013base states II. Effects on exercise performance and muscle and blood lactate. Eur J Appl Physiol Occup Physiol 57:445\u2013451","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"18_CR16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1249\/00005768-198510000-00013","volume":"17","author":"PH Hackett","year":"1985","unstructured":"Hackett PH, Schoene RB, Winslow RM, Paters RM Jr, West JB (1985) Acetazolamide and exercise in sojourners to 6,300 meters\u2013a preliminary study. Med Sci Sports Exerc 17:593\u2013597","journal-title":"Med Sci Sports Exerc"},{"key":"18_CR17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1113\/jphysiol.2006.120949","volume":"579","author":"AM Jonk","year":"2007","unstructured":"Jonk AM, van den Berg IP, Olfert IM, Wray DW, Arai T, Hopkins SR, Wagner PD (2007) Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise. J Physiol 579:909\u2013921","journal-title":"J Physiol"},{"key":"18_CR18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1152\/jappl.2000.88.2.713","volume":"88","author":"BW Scheuermann","year":"2000","unstructured":"Scheuermann BW, Kowalchuk JM, Paterson DH, Cunningham DA (2000) Carbonic anhydrase inhibition delays plasma lactate appearance with no effect on ventilatory threshold. J Appl Physiol 88:713\u2013721","journal-title":"J Appl Physiol"},{"key":"18_CR19","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0140-6736(86)91272-9","volume":"327","author":"Bradwell, A. R., Coote, J. H., Milles, J. J., Dykes, P. W., Forster, P. J. E., Chesner, I., and Richardson, N. V.; Birmingham Medical Research Expeditionary Society","year":"1986","unstructured":"Bradwell, A. R., Coote, J. H., Milles, J. J., Dykes, P. W., Forster, P. J. E., Chesner, I., and Richardson, N. V.; Birmingham Medical Research Expeditionary Society (1986) Effect of acetazolamide on exercise performance and muscle mass at high altitude. Lancet 327:1001\u20131005","journal-title":"Lancet"},{"key":"18_CR20","first-page":"79","volume":"61","author":"P Slavi","year":"2013","unstructured":"Slavi P, Revera M, Faini A, Giullian A, Gregorini F, Agostoni P, Becerra CG, Blio G, Lombardi C, O\u2019Rourke MF, Mancia G, Parati G (2013) Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide. Hypertension 61:79\u2013799","journal-title":"Hypertension"},{"key":"18_CR21","first-page":"543","volume":"57","author":"RF Larsen","year":"1986","unstructured":"Larsen RF, Rock PB, Fulco CS (1986) Effect of spironolactone on acute mountain sickness. Aviat Space Environ Med 57:543\u2013547","journal-title":"Aviat Space Environ Med"},{"key":"18_CR22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.wem.2010.10.009","volume":"22","author":"Basnyat, B., Holck, P. S., Pun, M., Halverson, S., Szawarski, P., Gertsch, J., Steif, M., Powell, S., Khanai, S., Shankar, R., Karambay, J., Alexander, H.D., Stone, A., Morrissey, C., Thompson, B. H., and Farrar, J.; SPACE Trial Group","year":"2011","unstructured":"Basnyat, B., Holck, P. S., Pun, M., Halverson, S., Szawarski, P., Gertsch, J., Steif, M., Powell, S., Khanai, S., Shankar, R., Karambay, J., Alexander, H.D., Stone, A., Morrissey, C., Thompson, B. H., and Farrar, J.; SPACE Trial Group (2011) Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group). Wilderness Environ Med 22:15\u201322","journal-title":"Wilderness Environ Med"},{"key":"18_CR23","first-page":"44","volume":"108","author":"RA Klocke","year":"1996","unstructured":"Klocke RA (1996) Potential role of endothelial carbonic anhydrase in dehydration of plasma bicarbonate. Trans Am Clin Climatol Assoc 108:44\u201357","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"18_CR24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1152\/jappl.1993.74.1.230","volume":"74","author":"ER Swenson","year":"1993","unstructured":"Swenson ER, Hughes JMB (1993) Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J Appl Physiol 74:230\u2013237","journal-title":"J Appl Physiol"},{"key":"18_CR25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0034-5687(78)90018-X","volume":"35","author":"ER Swenson","year":"1978","unstructured":"Swenson ER, Maren TH (1978) A quantitative analysis of CO2 transport at rest and during maximal exercise. Respir Physiol 35:129\u2013159","journal-title":"Respir Physiol"},{"key":"18_CR26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3565(25)32063-X","volume":"213","author":"BP Vogh","year":"1980","unstructured":"Vogh BP (1980) The relation of choroid plexus carbonic anhydrase activity to cerebro-spinal fluid formation: a study of three inhibitors in cat with extrapolation to man. J Pharmacol Exp Ther 213:321\u2013331","journal-title":"J Pharmacol Exp Ther"},{"key":"18_CR27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-0-387-74911-2_43","volume":"614","author":"I Tachtsidis","year":"2008","unstructured":"Tachtsidis I, Tisdall M, Delpy DT, Smith M, Elwell CE (2008) Measurement of cerebral tissue oxygenation in young healthy volunteers during acetazolamide provocation: a transcranial Doppler and near-infrared spectroscopy investigation. Adv Exp Med Biol 614:389\u2013396","journal-title":"Adv Exp Med Biol"},{"key":"18_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0034-5687(88)90090-4","volume":"72","author":"SY Huang","year":"1998","unstructured":"Huang SY, Mccullough RE, Mccullough RG, Micco AJ, Manco-Johnson M, Well JV, Reeves JT (1998) Usual clinical dose of acetazolamide does not alter cerebral blood-flow velocity. Respir Physiol 72:315\u2013326","journal-title":"Respir Physiol"},{"key":"18_CR29","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1152\/japplphysiol.01393.2010","volume":"110","author":"AW Subudhi","year":"2011","unstructured":"Subudhi AW, Dimmen AC, Julian CG, Wilson MJ, Paneral RB, Roach RC (2011) Effects of acetazolamide and dexamethasone on cerebral hemodynamics in hypoxia. J Appl Physiol 110:1219\u20131225","journal-title":"J Appl Physiol"},{"key":"18_CR30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/ham.2006.7.290","volume":"7","author":"J Vuyk","year":"2006","unstructured":"Vuyk J, Van Den Bos J, Terhell K, De Bos R, Vietter A, Valk P, Van Beuzekom M, Kleef JV, Dahan A (2006) Acetazolamide improves cerebral oxygenation during exercise at high altitude. High Alt Med Biol 7:290\u2013301","journal-title":"High Alt Med Biol"},{"key":"18_CR31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1113\/jphysiol.1991.sp018760","volume":"441","author":"LE Coates","year":"1991","unstructured":"Coates LE, Li A, Nattie EE (1991) Acetazolamide on the ventral medulla of the cat increases phrenic output and delays the ventilatory response to CO2. J Physiol 441:433\u2013451","journal-title":"J Physiol"},{"key":"18_CR32","doi-asserted-by":"crossref","first-page":"C565","DOI":"10.1152\/ajpcell.1991.261.4.C565","volume":"261","author":"R Iturriaga","year":"1991","unstructured":"Iturriaga R, Lahiri S, Mokashi A (1991) Carbonic anhydrase and chemoreception in the cat carotid body. Am J Physiol 261:C565\u2013C573","journal-title":"Am J Physiol"},{"key":"18_CR33","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1152\/jappl.1993.75.4.1587","volume":"75","author":"R Iturriaga","year":"1993","unstructured":"Iturriaga R, Mokashi A, Lahiri S (1993) Dynamics of carotid body responses in vitro in the presence of CO2\u2013HCO3-: role of carbonic anhydrase. J Appl Physiol 75:1587\u20131594","journal-title":"J Appl Physiol"},{"key":"18_CR34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0952-0600(90)90046-L","volume":"3","author":"Y Bashir","year":"1990","unstructured":"Bashir Y, Kann M, Stradling JR (1990) The effect of acetazolamide on hypercapnic and eucapnic\/poikilocapnic hypoxic ventilatory responses in normal subjects. Pulm Pharmacol 3:151\u2013154","journal-title":"Pulm Pharmacol"},{"key":"18_CR35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/rccm.200608-1199OC","volume":"175","author":"LJ Teppema","year":"2007","unstructured":"Teppema LJ, Balanos GM, Steinback CD, Brown AD, Foster GE, Duff HJ, Leigh R, Poulin MJ (2007) Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. Am J Respir Crit Care Med 175:277\u2013281","journal-title":"Am J Respir Crit Care Med"},{"key":"18_CR36","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1152\/jappl.1999.86.5.1544","volume":"86","author":"BW Scheuermann","year":"1999","unstructured":"Scheuermann BW, Kowalchuk JM, Paterson DH, Cunningham DA (1999) Peripheral chemoreceptor function after carbonic anhydrase inhibition during moderat-intensity exercise. J Appl Physiol 86:1544\u20131551","journal-title":"J Appl Physiol"},{"key":"18_CR37","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1164\/ajrccm.160.5.9903088","volume":"160","author":"LJ Teppema","year":"1999","unstructured":"Teppema LJ, Dahan A (1999) Acetazolamide and breathing. Does a clinical dose alter peripheral and central CO2 sensitivity? Am J Respir Crit Care Med 160:1592\u20131597","journal-title":"Am J Respir Crit Care Med"},{"key":"18_CR38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1113\/jphysiol.2006.110528","volume":"574","author":"LJ Teppema","year":"2006","unstructured":"Teppema LJ, Bijl H, Mousavi-Gourabi B, Dahan A (2006) The carbonic anhydrase inhibitors methazolamide and acetazolamide have different effects on the hypoxic ventilatory response in the anaesthetized cat. J Physiol 574:565\u2013572","journal-title":"J Physiol"},{"key":"18_CR39","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/arrd.1987.135.4.896","volume":"135","author":"PH Hackett","year":"1987","unstructured":"Hackett PH, Roach RC, Harrison GL, Schoene RB, Mills WJ Jr (1987) Respiratory stimulants and sleep periodic breathing at high altitude Almitrine versus acetazolamide. Am Rev Respir Dis 135:896\u2013898","journal-title":"Am Rev Respir Dis"},{"key":"18_CR40","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1001\/jama.2012.94847","volume":"308","author":"TD Latshang","year":"2012","unstructured":"Latshang TD, Nussbauemer-Ochsner Y, Heen RM, Ulrich CM, Lo Cascio CM, Ledergerber B, Kohler M, Bloch KE (2012) Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a ramdomized controlled trial. J Am Med Assoc 308:2390\u20132398","journal-title":"J Am Med Assoc"},{"key":"18_CR41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1113\/expphysiol.2004.028985","volume":"90","author":"JA Dempsey","year":"2005","unstructured":"Dempsey JA (2005) Crossing the apnoeic threshold: causes and consequences. Exp Physiol 90:13\u201324","journal-title":"Exp Physiol"},{"key":"18_CR42","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1152\/japplphysiol.00911.2006","volume":"102","author":"PN Ainslie","year":"2007","unstructured":"Ainslie PN, Burgess K, Subedi P, Burgess KR (2007) Alterations in cerebral dynamics at high altitude following partial acclimatization in humans: wakefulness and sleep. J Appl Physiol 102:658\u2013664","journal-title":"J Appl Physiol"},{"key":"18_CR43","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00424-011-1002-x","volume":"462","author":"M Herrera","year":"2011","unstructured":"Herrera M, Garvin JL (2011) Aquaporins as gas channels. Pflugers Arch 462:623\u2013630","journal-title":"Pflugers Arch"},{"key":"18_CR44","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1096\/fj.12-209916","volume":"26","author":"F Itel","year":"2012","unstructured":"Itel F, Al-Samir S, \u00d6berg F, Chami M, Kumar M, Supuran CT, Deen PM, Meier W, Hedfalk K, Gros G, Endeward V (2012) CO2 permeability of cell membranes is regulated by membrane cholesterol and protein gas channels. FASEB J 26:5182\u20135191","journal-title":"FASEB J"},{"key":"18_CR45","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.mam.2012.03.008","volume":"33","author":"O Benga","year":"2012","unstructured":"Benga O, Huber VJ (2012) Brain water channel proteins in health and disease. Mol Aspects Med 33:562\u2013578","journal-title":"Mol Aspects Med"},{"key":"18_CR46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-7091-0923-6_13","volume":"113","author":"PA Ameli","year":"2012","unstructured":"Ameli PA, Madan M, Chigurupati S, Yu A, Chan SL, Pattisapu JV (2012) Effect of acetazolamide on aquaporin-1 and fluid flow in cultured choroid plexus. Acta Neurochir Suppl 113:59\u201364","journal-title":"Acta Neurochir Suppl"},{"key":"18_CR47","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/WNR.0b013e32835fc827","volume":"24","author":"H Igarashi","year":"2013","unstructured":"Igarashi H, Tsujita M, Suzuki Y, Kwee IL, Nakada T (2013) Inhibition of aquaporin-4 significantly increases regional brain blood flow. Neuroreport 24:324\u2013328","journal-title":"Neuroreport"},{"key":"18_CR48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2012.10.065","volume":"1491","author":"C Zanotto","year":"2013","unstructured":"Zanotto C, Abib RT, Batassini C, Tortorelli LS, Biasbetti R, Rodrigues L, Nardin P, Hansen F, Gottfried C, Leite MC, Goncalves CA (2013) Non-specific inhibitors of aquaporin-4 stimulate S100-B secretion in acute hippocampal slices of rats. Brain Res 1491:14\u201322","journal-title":"Brain Res"},{"key":"18_CR49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10072-010-0431-1","volume":"32","author":"H Igarashi","year":"2011","unstructured":"Igarashi H, Huber VJ, Tsujita M, Nakuda T (2011) Pretreatment with a novel aquaporin-4 inhibitor significantly reduces ischemic cerebral edema. Neurol Sci 32:113\u2013116","journal-title":"Neurol Sci"},{"key":"18_CR50","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.bbamem.2006.02.018","volume":"1758","author":"AS Verkman","year":"2006","unstructured":"Verkman AS, Binder DK, Bloch O, Auguste K, Papadopoulos MC (2006) Three distinct roles of aquaporin-4 in brain function revealed by knockout mice. Biochim Biophys Acta 1758:1085\u20131093","journal-title":"Biochim Biophys Acta"},{"key":"18_CR51","doi-asserted-by":"crossref","first-page":"e45976","DOI":"10.1371\/journal.pone.0045976","volume":"7","author":"J Zhang","year":"2012","unstructured":"Zhang J, An Y, Gao J, Han J, Xueyang P, Pan Y, Tie L, Li X (2012) Aquaporin-1 translocation and degradation mediates the water transportation mechanism of acetazolamide. PLoS One 7:e45976","journal-title":"PLoS One"},{"key":"18_CR52","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bmc.2007.12.038","volume":"17","author":"VJ Huber","year":"2009","unstructured":"Huber VJ, Tsujita M, Kwee IL, Nakada T (2009) Inhibition of aquaporin-4 by antiepileptic drugs. Bioorg Med Chem 17:418\u2013424","journal-title":"Bioorg Med Chem"},{"key":"18_CR53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsb.2008.11.010","volume":"166","author":"Y Tanimura","year":"2009","unstructured":"Tanimura Y, Hiroaki Y, Fujiyoshi Y (2009) Acetazolamide reversibly inhibits water conduction by aquaporin-4. J Struct Biol 166:16\u201321","journal-title":"J Struct Biol"},{"key":"18_CR54","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1248\/bpb.b12-00581","volume":"35","author":"T Yamaguchi","year":"2012","unstructured":"Yamaguchi T, Iwata Y, Miura S, Kawada K (2012) Reinvestigation of drugs and chemicals as aquaporin-1 inhibitors using pressure-induced hemolysis in human erythrocytes. Biol Pharm Bull 35:2088\u20132091","journal-title":"Biol Pharm Bull"},{"key":"18_CR55","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1016\/j.bmc.2008.06.005","volume":"16","author":"B Yang","year":"2008","unstructured":"Yang B, Zhang H, Verkmann AS (2008) Lack of aquaporin-4 water transport inhibition by antiepileptics and arylsulfonamides. Bioorg Med Chem 16:7489\u20137493","journal-title":"Bioorg Med Chem"},{"key":"18_CR56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00424-007-0392-2","volume":"456","author":"R Sogaard","year":"2008","unstructured":"Sogaard R, Zeuthen T (2008) Test of blockers of AQP-1 water permeability by a high resolution method: no effects of tetraethylammonium ions or acetazolamide. Pflugers Arch 456:285\u2013292","journal-title":"Pflugers Arch"},{"key":"18_CR57","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1227\/00006123-197912000-00002","volume":"5","author":"RD Harbaugh","year":"1979","unstructured":"Harbaugh RD, James HE, Marshall LF, Shapiro HM, Laurin R (1979) Acute therapeutic modalities for experimental vasogenic edema. Neurosurgery 5:656\u2013665","journal-title":"Neurosurgery"},{"key":"18_CR58","first-page":"329","volume":"60","author":"Z Czernicki","year":"1994","unstructured":"Czernicki Z, Kuroiwa T, Ohno K, Endo S, Ito U (1994) Effect of acetazolamide on early ischemic cerebral edema in gerbils. Acta Neurochir Suppl 60:329\u2013331","journal-title":"Acta Neurochir Suppl"},{"key":"18_CR59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF01407228","volume":"56","author":"C Millson","year":"1981","unstructured":"Millson C, James HE, Shapiro HM, Laurin R (1981) Intracranial hypertension and brain edema in albino rabbits. Effects of acute therapy with diuretics. Acta Neurochir 56:167\u2013181","journal-title":"Acta Neurochir"},{"key":"18_CR60","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12975-011-0106-0","volume":"3","author":"F Guo","year":"2012","unstructured":"Guo F, Hua Y, Wang J, Keep RF, Xi G (2012) Inhibition of carbonic anhydrase reduces brain injury after intracerebral hemorrhage. Transl Stroke Res 3:130\u2013137","journal-title":"Transl Stroke Res"},{"key":"18_CR61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajpath.2011.09.011","volume":"180","author":"R Katada","year":"2012","unstructured":"Katada R, Nishitani Y, Honmou O, Mizuo K, Okazaki S, Tateda K, Watanabe S, Matsumoto H (2012) Expression of aquaporin-4 augments cytotoxic barin edema after traumatic brain injury during acute ethanol exposure. Am J Pathol 180:17\u201323","journal-title":"Am J Pathol"},{"key":"18_CR62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00380-009-1179-5","volume":"25","author":"X Ran","year":"2010","unstructured":"Ran X, Wang H, Chen Y, Zeng Z, Zhou Q, Zheng R, Sun J, Wang B, Lv X, Liang Y, Zhang K, Liu W (2010) Aquaporin-1 expression and angiogenesis in rabbit chronic myocardial ischemia is reduced by acetazolamide. Heart Vessels 25:237\u2013247","journal-title":"Heart Vessels"},{"key":"18_CR63","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1113\/jphysiol.2010.194704","volume":"588","author":"DM Bailey","year":"2010","unstructured":"Bailey DM, Dehnert C, Luks AM, Menold E, Castell C, Schendlev G, Faoro V, Gutoski M, Evans KA, Taudorf S, James PE, McEneny J, Young IS, Swenson ER, Mairb\u00e4url H, B\u00e4rtsch P, Bergef MM (2010) High-altitude pulmonary hypertension is associated with a free radical-mediated reduction in pulmonary nitric oxide bioavailability. J Physiol 588:4837\u20134847","journal-title":"J Physiol"},{"key":"18_CR64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.jcbfm.9600169","volume":"26","author":"DM Bailey","year":"2006","unstructured":"Bailey DM, Roukens R, Knauth M, Kallenberg K, Christ S, Mohr A, Genius J, Storch-Hagenlocher B, Meisel F, McEneny J, Young IS, Steiner T, Hess K, B\u00e4rtsch P (2006) Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab 26:99\u2013111","journal-title":"J Cereb Blood Flow Metab"},{"key":"18_CR65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/152702901750067882","volume":"2","author":"DM Bailey","year":"2001","unstructured":"Bailey DM, Davies B (2001) Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude. High Alt Med Biol 2:21\u201329","journal-title":"High Alt Med Biol"},{"key":"18_CR66","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.freeradbiomed.2009.01.016","volume":"46","author":"C Prouillac","year":"2009","unstructured":"Prouillac C, Vicendo P, Garrigues JC, Poteau R, Rima G (2009) Evaluation of new thiadiazoles and benzothiazoles as potential radioprotectors: free radical scavenging activity in vitro and theoretical studies (QSAR, DFT). Free Radic Biol Med 46:1139\u20131148","journal-title":"Free Radic Biol Med"},{"key":"18_CR67","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1113\/jphysiol.2005.104174","volume":"572","author":"LJ Teppema","year":"2006","unstructured":"Teppema LJ, Bijl H, Romberg R, Dahan A (2006) Antioxidants reverse depression of the hypoxic ventilatory response by acetazolamide in man. J Physiol 572:849\u2013856","journal-title":"J Physiol"},{"key":"18_CR68","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2013.05.024","volume":"63","author":"C Lisk","year":"2013","unstructured":"Lisk C, McCord J, Bose S et al (2013) Irwin1Nrf-2 activation: a potential strategy for the prevention of acute mountain sickness. Free Rad Biol Med 63:264\u2013273","journal-title":"Free Rad Biol Med"},{"key":"18_CR69","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1152\/japplphysiol.00391.2011","volume":"111","author":"GJ Julian","year":"2011","unstructured":"Julian GJ, Subudhi AW, Wilson MJ, Dimmen AC, Pecha T, Roach RC (2011) Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study. J Appl Physiol 111:392\u2013399","journal-title":"J Appl Physiol"},{"key":"18_CR70","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neulet.2009.01.008","volume":"451","author":"J Xu","year":"2009","unstructured":"Xu J, Peng Z, Li R, Dou T, Xu W, Gu G, Liu Y, Kang Z, Tao H, Zhang JH, Ostrowski RP, Lu J, Sun X (2009) Normoxic induction of cerebral HIF-1alpha by acetazolamide in rats. Neurosci Lett 451:274\u2013278","journal-title":"Neurosci Lett"},{"key":"18_CR71","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00424-005-1486-3","volume":"451","author":"C Willam","year":"2006","unstructured":"Willam C, Warnecke C, Schefold JC, K\u00fcgler J, Koehne P, Frei U, Wiesener M, Eckardt KU (2006) Inconsistent effects of acidosis on HIF-alpha protein and its target genes. Pfluegers Arch 451:534\u2013543","journal-title":"Pfluegers Arch"},{"key":"18_CR72","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3357\/ASEM.2361.2008","volume":"79","author":"Y Droma","year":"2008","unstructured":"Droma Y, Ota M, Hanaoka M, Katsuyama Y, Basnyat B, Neupane P, Arjyal A, Pandit A, Sharma D, Ito M, Kubo K (2008) Two hypoxia sensor genes and their association with symptoms of acute mountain sickness in Sherpas. Avait Space Environ Med 79:1056\u20131060","journal-title":"Avait Space Environ Med"},{"key":"18_CR73","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.wem.2010.05.001","volume":"21","author":"PJ Hennis","year":"2010","unstructured":"Hennis PJ, Bussell C, Darlison MG (2010) The lack of associations between alleles at the hypoxia-inducible factor 1A C1772T loci and response to acute hypoxia. Wilderness Environ Med 21:219\u2013228","journal-title":"Wilderness Environ Med"},{"key":"18_CR74","doi-asserted-by":"crossref","first-page":"e6779","DOI":"10.1136\/bmj.e6779","volume":"345","author":"EV Low","year":"2012","unstructured":"Low EV, Avery AJ, Gupta V, Schedlbauer A, Grocott MP (2012) Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis. Br Med J 345:e6779","journal-title":"Br Med J"},{"key":"18_CR75","first-page":"619","volume":"54","author":"AD Wright","year":"1983","unstructured":"Wright AD, Bradwell AR, Fletcher RF (1983) Methazolamide and acetazolamide in acute mountain sickness. Aviat Space Environ Med 54:619\u2013621","journal-title":"Aviat Space Environ Med"},{"key":"18_CR76","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(82)92385-6","volume":"8283","author":"P Forster","year":"1982","unstructured":"Forster P (1982) Methazolamide in acute mountain sickness. Lancet 8283:1254","journal-title":"Lancet"},{"key":"18_CR77","first-page":"296","volume":"39","author":"RS Kronenberg","year":"1968","unstructured":"Kronenberg RS, Cain SM (1968) Hastening respiratory acclimatisation to altitude with benzolamide (CL 11366). Aerospace Med 39:296\u2013300","journal-title":"Aerospace Med"},{"key":"18_CR78","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0034-5687(91)90104-Q","volume":"86","author":"ER Swenson","year":"1991","unstructured":"Swenson ER, Leatham KL, Roach RC, Schoene RB, Mills WJ Jr, Hacket HP (1991) Renal carbonic anhydrase inhibition reduces high altitude sleep periodic breathing. Respir Physiol 86:333\u2013343","journal-title":"Respir Physiol"},{"key":"18_CR79","unstructured":"Collier D, Swenson ER, Hedges AM et al (2013) Benzolamide improves oxygenation and reduces acute mountain sickness during a high altitude trek and has less side effects than acetazolamide. Brit J Clin Pharmacol (in press)"},{"key":"18_CR80","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-116-6-461","volume":"116","author":"CK Grissom","year":"1992","unstructured":"Grissom CK, Roach RC, Sarnquist FH, Hackett PH (1992) Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med 116:461\u2013465","journal-title":"Ann Intern Med"},{"key":"18_CR81","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ntt.2012.12.003","volume":"35","author":"J Wang","year":"2013","unstructured":"Wang J, Ke T, Zhang X, Chen Y, Liu M, Chen J, Luo W (2013) Effects of acetazolamide on cognitive performance during high-altitude exposure. Neurotoxicol Teratol 35:28\u201333","journal-title":"Neurotoxicol Teratol"},{"key":"18_CR82","first-page":"211","volume":"135","author":"A Vij","year":"2012","unstructured":"Vij A, Kishore K, Dey J (2012) Effect of intermittent hypoxia on efficacy and clearance of drugs. Indian J Med Res 135:211\u2013216","journal-title":"Indian J Med Res"},{"key":"18_CR83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ham.2012.1080","volume":"14","author":"Y Botao","year":"2013","unstructured":"Botao Y, Ma J, Xiao W, Xiang Q, Fan K, Hou J, Wu J, Jing W (2013) Protective effects of gingkolide B on high altitude cerebral edema of rats. High Alt Med Biol 14:61\u201364","journal-title":"High Alt Med Biol"},{"key":"18_CR84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1152\/japplphysiol.00926.2005","volume":"100","author":"CA Smith","year":"2006","unstructured":"Smith CA, Rodman JR, Chenuel BJ, Henderson KS, Dempsey JA (2006) Response time and sensitivity of the ventilatory response to CO2 in unanesthetized dogs: central vs. peripheral chemoreceptors. J Appl Physiol 100:13\u201319","journal-title":"J Appl Physiol"},{"key":"18_CR85","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1152\/japplphysiol.01167.2004","volume":"93","author":"P Bartsch","year":"2005","unstructured":"Bartsch P, Mairbaurl H, Maggiorini M, Swenson ER (2005) Physiological aspects of high-altitude pulmonary edema. J Appl Physiol 93:1101\u20131110","journal-title":"J Appl Physiol"},{"key":"18_CR86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/ham.2013.1010","volume":"14","author":"ER Swenson","year":"2013","unstructured":"Swenson ER (2013) Hypoxic pulmonary vasoconstriction. High Alt Med Biol 14:101\u2013110","journal-title":"High Alt Med Biol"},{"key":"18_CR87","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/01.CIR.103.16.2078","volume":"103","author":"M Maggiorini","year":"2001","unstructured":"Maggiorini M, Melot C, Pierre S, Pfeiffer F, Greve I, Sartori C, Lepori M, Hauser M, Scherrer U, Naeije R (2001) High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 103:2078\u20132083","journal-title":"Circulation"},{"key":"18_CR88","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1001\/jama.287.17.2228","volume":"287","author":"ER Swenson","year":"2002","unstructured":"Swenson ER, Maggiorini M, Mongovin S, Gibbs JS, Greve I, Mairb\u00e4url H, B\u00e4rtsch P (2002) Pathogenesis of high altitude pulmonary edema. Inflammation is not a pathogenic factor. J Am Med Assoc 287:2228\u20132235","journal-title":"J Am Med Assoc"},{"key":"18_CR89","first-page":"763","volume":"13","author":"CJ Emery","year":"1977","unstructured":"Emery CJ, Sloan PJ, Mohammed FH, Barer GR (1977) Action of hypercapnia during hypoxia on pulmonary vessels. Bull Eur Physiopath Respir 13:763\u2013776","journal-title":"Bull Eur Physiopath Respir"},{"key":"18_CR90","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1172\/JCI116640","volume":"92","author":"ER Swenson","year":"1993","unstructured":"Swenson ER, Robertson HT, Hlastala MP (1993) Effects of carbonic anhydrase inhibition on ventilation\u2013perfusion matching in the dog lung. J Clin Invest 92:702\u2013709","journal-title":"J Clin Invest"},{"key":"18_CR91","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1152\/jappl.1995.78.4.1312","volume":"78","author":"ER Swenson","year":"1995","unstructured":"Swenson ER, Graham MM, Hlastala MP (1995) Acetazolamide slows ventilation-perfusion matching after changes in regional blood flow. J Appl Physiol 78:1312\u20131318","journal-title":"J Appl Physiol"},{"key":"18_CR92","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0034-5687(00)00148-1","volume":"123","author":"S Deem","year":"2000","unstructured":"Deem S, Hedges RG, Kerr ME, Swenson ER (2000) Acetazolamide reduces hypoxic pulmonary vasoconstriction in isolated perfused rabbit lung. Respir Physiol 123:109\u2013119","journal-title":"Respir Physiol"},{"key":"18_CR93","first-page":"H2068","volume":"297","author":"R Aamand","year":"2009","unstructured":"Aamand R, Dalsgaard T, Jensen FB, Simonsen U, Roepstorff A, Fago A (2009) Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. Am J Physiol 297:H2068\u2013H2074","journal-title":"Am J Physiol"},{"key":"18_CR94","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/ALN.0b013e3182655f80","volume":"117","author":"PA Pickerodt","year":"2012","unstructured":"Pickerodt PA, Emery MJ, Zarndt R, Martin W, Francis RC, Boemke W, Swenson ER (2012) Sodium nitrite mitigates ventilator-induced lung injury in rats. Anesthesiol 117:592\u2013601","journal-title":"Anesthesiol"},{"key":"18_CR95","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.niox.2012.01.005","volume":"26","author":"K Chobanyan-J\u00fcrgens","year":"2012","unstructured":"Chobanyan-J\u00fcrgens K, Schwarz A, B\u00f6hmer A, Beckmann B, Gutzki FM, Michaelsen JT, Stichtenoth DO, Tsikas D (2012) Renal carbonic anhydrases are involved in the reabsorption of endogenous nitrite. Nitric Oxide 26:126\u2013129","journal-title":"Nitric Oxide"},{"key":"18_CR96","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/japplphysiol.01217.2003","volume":"97","author":"C Hohne","year":"2004","unstructured":"Hohne C, Krebs MO, Seiferheld M, Boemke W, Kaczmarczyk G, Swenson ER (2004) Acetazolamide prevents hypoxic pulmonary vasoconstriction in conscious dogs. J Appl Physiol 97:515\u2013521","journal-title":"J Appl Physiol"},{"key":"18_CR97","doi-asserted-by":"crossref","first-page":"L178","DOI":"10.1152\/ajpcell.00162.2006","volume":"292","author":"C H\u00f6hne","year":"2007","unstructured":"H\u00f6hne C, Pickerodt PA, Boemke W, Swenson ER (2007) Pulmonary vasodilation by acetazolamide during hypoxia is not related to carbonic anhydrase inhibition. Am J Physiol 292:L178\u2013L184","journal-title":"Am J Physiol"},{"key":"18_CR98","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1369\/jhc.4A6266.2004","volume":"52","author":"JT Berg","year":"2004","unstructured":"Berg JT, Ramanathan S, Gabrielli MG, Swenson ER (2004) Carbonic anhydrase in mammalian vascular smooth muscle. J Histochem Cytochem 52:1101\u20131106","journal-title":"J Histochem Cytochem"},{"key":"18_CR99","first-page":"L1002","volume":"292","author":"LA Shimoda","year":"2007","unstructured":"Shimoda LA, Luke T, Sylvester JT, Shih HW, Jain A, Swenson ER (2007) Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition. Am J Physiol 292:L1002\u2013L1012","journal-title":"Am J Physiol"},{"key":"18_CR100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1152\/physrev.1967.47.4.595","volume":"47","author":"TH Maren","year":"1967","unstructured":"Maren TH (1967) Carbonic anhydrase: chemistry, physiology and inhibition. Physiol Rev 47:595\u2013781","journal-title":"Physiol Rev"},{"key":"18_CR101","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1254\/jphs.FP0040032","volume":"95","author":"NC McNaughton","year":"2004","unstructured":"McNaughton NC, Davies CH, Randall A (2004) Inhibition of alpha (1E) Ca (2+) channels by carbonic anhydrase inhibitors. J Pharmacol Sci 95:240\u2013247","journal-title":"J Pharmacol Sci"},{"key":"18_CR102","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1096\/fj.03-0722fje","volume":"18","author":"D Tricarico","year":"2004","unstructured":"Tricarico D, Barbieri M, Mele A, Carbonara G, Camerino DC (2004) Carbonic anhydrase inhibitors: specific openers of skeletal muscle BK channel of K\u2009+\u2009\u2212deficient rats. FASEB J 18:760\u2013761","journal-title":"FASEB J"},{"key":"18_CR103","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1152\/jappl.1996.80.2.496","volume":"80","author":"IS Farrukh","year":"1996","unstructured":"Farrukh IS, Hoidal JR, Barry WH (1996) Effect of intracellular pH on ferret pulmonary arterial smooth muscle cell calcium homeostasis and pressure. J Appl Physiol 80:496\u2013505","journal-title":"J Appl Physiol"},{"key":"18_CR104","first-page":"L1059","volume":"288","author":"J Wang","year":"2005","unstructured":"Wang J, Shimoda LA, Weigand L, Wang W, Sun D, Sylvester JT (2005) Acute hypoxia increases intracellular [Ca2+] in pulmonary arterial smooth muscle by enhancing capacitative Ca2+ entry. Am J Physiol 288:L1059\u2013L1069","journal-title":"Am J Physiol"},{"key":"18_CR105","first-page":"F291","volume":"232","author":"TH Maren","year":"1977","unstructured":"Maren TH (1977) Use of inhibitors in physiological studies of carbonic anhydrase. Am J Physiol 232:F291\u2013F297","journal-title":"Am J Physiol"},{"key":"18_CR106","doi-asserted-by":"crossref","unstructured":"Pickerodt PA, Francis RC, Neubert F et al (2013) Pulmonary vasodilation by acetazolamide during hypoxia: impact of methyl-group substitution and route of administration in the conscious, spontaneously breathing dog. J Pharmacol Exp Therap (in press)","DOI":"10.1152\/japplphysiol.01235.2013"},{"key":"18_CR107","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/ham.2012.1099","volume":"14","author":"T Ke","year":"2013","unstructured":"Ke T, Wang, J, Swenson ER (2013) Effect of acetazolamide and gingko biloba on the human pulmonary vascular response to an acute altitude ascent. High Alt Med Biol 14:162\u2013167","journal-title":"High Alt Med Biol"},{"key":"18_CR108","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/ham.2007.1073","volume":"9","author":"B Basnyat","year":"2008","unstructured":"Basnyat B, Hargrove J, Holck PS, Srivastav S, Alekh K, Ghimire LV, Pandey K, Griffiths A, Shankar R, Kaul K, Paudyal A, Stasiuk D, Basnyat R, Davis C, Southard A, Robinson C, Shandley T, Johnson DW, Zafren K, Williams S, Weiss EA, Farrar JJ, Swenson ER (2008) Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans. High Alt Med Biol 9:209\u2013216","journal-title":"High Alt Med Biol"},{"key":"18_CR109","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.HYP.33.4.1043","volume":"33","author":"P Pickkers","year":"1999","unstructured":"Pickkers P, Garcha RS, Schachter M, Smits P, Hughes AD (1999) Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension 33:1043\u20131048","journal-title":"Hypertension"},{"key":"18_CR110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjp.0703825","volume":"132","author":"P Pickkers","year":"2001","unstructured":"Pickkers P, Hughes AD, Russel FG, Thien T, Smits P (2001) In vivo evidence for K(Ca) channel opening properties of acetazolamide in the human vasculature. Br J Pharmacol 132:443\u2013450","journal-title":"Br J Pharmacol"},{"key":"18_CR111","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1580\/1080-6032(2004)015[0032:IOHPVP]2.0.CO;2","volume":"15","author":"JT Berg","year":"2004","unstructured":"Berg JT, Ramanathan S, Swenson ER (2004) Inhibition of hypoxic pulmonary vasoconstriction prevents high altitude pulmonary edema (HAPE) in rats. Wilderness Environ Med 15:32\u201337","journal-title":"Wilderness Environ Med"},{"key":"18_CR112","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/ham.2006.7.125","volume":"7","author":"F Leon-Velarde","year":"2006","unstructured":"Leon-Velarde F, Richalet JP (2006) Respiratory control in residents at high altitude; physiology and pathophysiology. High Alt Med Biol 7:125\u2013137","journal-title":"High Alt Med Biol"},{"key":"18_CR113","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1378\/chest.12-0933","volume":"142","author":"ER Swenson","year":"2012","unstructured":"Swenson ER (2012) Normal exercise capacity in chronic mountain sickness: how high can the hematocrit go without consequence? Chest 142:823\u2013825","journal-title":"Chest"},{"key":"18_CR114","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.resp.2007.05.003","volume":"158","author":"M Rivera-Ch","year":"2007","unstructured":"Rivera-Ch M, Leon-Velarde F, Huicho L (2007) Treatment of chronic mountain sickness; critical reappraisal of an old problem. Respir Physiol Neurobiol 158:251\u2013265","journal-title":"Respir Physiol Neurobiol"},{"key":"18_CR115","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1164\/rccm.200505-807OC","volume":"172","author":"JP Richalet","year":"2005","unstructured":"Richalet JP, Rivera M, Bouchet P, Chirinos E, Onnen I, Petitjean O, Bienvenu A, Lasne F, Moutereau S, Le\u00f3n-Velarde F (2005) Acetazolamide: a treatment of chronic mountain sickness. Am J Respir Crit Care Med 172:1427\u20131433","journal-title":"Am J Respir Crit Care Med"},{"key":"18_CR116","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1164\/rccm.200802-196OC","volume":"177","author":"JP Richalet","year":"2008","unstructured":"Richalet JP, Rivera-Ch M, Maignan M, Privat C, Pham I, Macarlupu JL, Petitjean O, Le\u00f3n-Velarde F (2008) Acetazolamide for Monge\u2019s disease: efficacy and tolerance of 6-month treatment. Am J Respir Crit Care Med 177:1370\u20131376","journal-title":"Am J Respir Crit Care Med"},{"key":"18_CR117","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.resp.2008.06.010","volume":"162","author":"M Rivera-Ch","year":"2008","unstructured":"Rivera-Ch M, Huicho L, Bouchet P, Richalet JP, Le\u00f3n-Velarde F (2008) Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness. Respir Physiol Neurobiol 162:184\u2013189","journal-title":"Respir Physiol Neurobiol"},{"key":"18_CR118","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1183\/09031936.00216011","volume":"40","author":"A Pichon","year":"2012","unstructured":"Pichon A, Connes P, Quidu P, Marchant D, Brunet J, Levy BI, Vilar J, Safeukui I, Cymbalista F, Maignan M, Richalet JP, Favret F (2012) Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics. Eur Respir J 40:1401\u20131409","journal-title":"Eur Respir J"},{"key":"18_CR119","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.pcad.2010.02.012","volume":"52","author":"F Leon-Velarde","year":"2010","unstructured":"Leon-Velarde F, Villafuerte FC, Richalet JP (2010) Chronic mountain sickness and the heart. Prog Cardiovasc Dis 52:540\u2013549","journal-title":"Prog Cardiovasc Dis"},{"key":"18_CR120","first-page":"F942","volume":"256","author":"KU Eckardt","year":"1989","unstructured":"Eckardt KU, Kurtz A, Bauer C (1989) Regulation of erythropoietin production is related to proximal tubular function. Am J Physiol 256:F942\u2013F947","journal-title":"Am J Physiol"},{"key":"18_CR121","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJM197304052881404","volume":"288","author":"ME Miller","year":"1973","unstructured":"Miller ME, Rorth M, Parving H, Howard D, Reddington I, Valeri CR, Stohlman F Jr (1973) pH effect on erythropoietin response to hypoxia. N Engl J Med 288:706\u2013710","journal-title":"N Engl J Med"}],"container-title":["Subcellular Biochemistry","Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-7359-2_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T17:44:28Z","timestamp":1746035068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-7359-2_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,17]]},"ISBN":["9789400773585","9789400773592"],"references-count":121,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-7359-2_18","relation":{},"ISSN":["0306-0225"],"issn-type":[{"value":"0306-0225","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,17]]},"assertion":[{"value":"17 September 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}